KMC Speciality Hospitals (India) Ltd.
Snapshot View

38.40 -0.50 ▼-1.3%

03 August 2021, 04:00:00 P.M.
Volume: 88,510

Overview View Details

Sector Healthcare Compare with Sector peers
Industry Hospital & Healthcare Services Compare with Industry peers
Website http://www.kauveryhospital.com
Financial Indicators
Market Cap 626.25 Cr.
Earnings per share (EPS) 0.78 Trailing Twelve Months Ending 2021-03
Price-Earning Ratio (PE) 49.00 Trailing Twelve Months Ending 2021-03
Industry PE 207.73 Trailing Twelve Months Ending 2021-03
Book Value / Share 3.88 Trailing Twelve Months Ending 2021-03
Price to Book Value 9.89 Calculated using Price: 38.40
Dividend Yield 0.00 Period Ending 2020-03
No. of Shares Subscribed 16.31 Cr. 163,085,000 Shares
FaceValue 1
Company Profile

KMC Speciality Hospital (I), formerly Seahorse Hospitals Ltd is a renowned hospital situated in Trichy was incorporated in 1999. The hospital boasts of a 24-hour cardiac care with facilities comparable to metropolitan cities like Chennai, Bangalore, Mumbai, etc.

KMC hospital, in its decennial year of operations has added numerous feathers to its cap.From a humble beginning of 30 beds in 1999 it has come a long way to 400 beds by acquiring Seahorse Hospital. The number of doctors in the hospital has grown from 10 to 100 and the satff members have grown to over 1000.

Seahorse hospital management was taken over by KMC by the end of February 2008 .Now all the procedural formalities have been completed and hence forth it will be called as KMC Speciality Hospital, has came into effect from December 12 2008. KMC Group of Hospitals is planning to invest further Rs.10 crore to upgrade all the existing facilities.

To reaffirm the high level of healthcare which they are providing, they have started the accreditaion process for National Accreditaion Board for Hospital (NABH) and for National Accreditaion Board for Laboratories (NABL). The hospital has full time consultants in all the basic specialties. Especially Obstetrics & Gynaecology, Paediatrics, Cardiology, ENT, Dental, Joint Replacement, Plastic Surgery, Neurology, diabetology, etc. The hospital will be starting infertility Management very soon.

KMC Speciality Hospitals (I)  has an out patient department exclusively like Coronary artery disease clinic, Pediatric Cardiology, Vascular Heart disease clinic, Arrhythmia Clinic, Cardiovascular surgery department.

KMC Speciality Hospitals (I) , offers a comprehensive cardiac health check up scheme called 'Healthy Heart'.This includes a detailed cardiac examination by physicians and cardiologist followed by a wide range of investigations that include blood tests, to check for diabetes, high cholesterol and kidney disease, urine tests, ECG, Echo 2D etc.

Services offered by the company :

Specialties services:

  • Cardiology
  • Accident & Emergency
  • Diabetology
  • Dentistry
  • ENT
  • Orthopaedics
  • Obstetrics & Gynaecology
  • Paediatrics and Neonatology
  • Gastroenterology
  • Laproscopic Surgery
  • Opthalmology
  • Psychiatry
  • Rheumatology
  • General medicine
  • Urology and Nephrology

Other services:

  • Ambulance Services 
  • Blood Bank 
  • Labortatory
  • Pharmacy
  • Radiology

Delivery View Details

Delivered Qty
Traded Qty

Performance View Details

1 Day
-1.29%
1 Week
+0.26%
1 Month
-1.03%
3 Month
+1.05%
6 Month
+66.23%
1 Year
+92.96%
2 Year
+267.82%
5 Year
+412.00%
9 years 2012-03 2013-03 2014-03 2015-03 2016-03 2017-03 2018-03 2019-03 2020-03
Return on Equity (%) 6.67 7.24 -2.52 1.22 27.24 28.60 24.43 24.78 26.17
Return on Capital Employed (%) 11.24 17.95 2.37 8.53 23.92 34.73 28.63 29.11 33.09
Return on Assets (%) 2.97 2.87 -0.88 0.38 10.63 17.14 16.30 16.40 19.13

Balance Sheet View Details

Particulars 9 years 2012-03 Rs. Cr. 2013-03 Rs. Cr. 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr.
Shh. Funds 12 13 10 10 13 24 30 39 51
Non Curr. Liab. 15 15 14 12 6 -1 7 5 3
Curr. Liab. 4 6 9 9 10 10 12 12 12
Minority Int.
Equity & Liab. 31 34 33 31 29 33 49 56 66
Non Curr. Assets 26 32 31 28 27 29 41 44 49
Curr. Assets 5 3 3 3 3 4 8 13 18
Misc. Exp. not W/O
Total Assets 31 34 33 31 29 33 49 56 66

Profit Loss View Details

Particulars 9 years 2012-03 Rs. Cr. 2013-03 Rs. Cr. 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr.
Net Sales 20 29 32 36 43 55 71 82 96
Other Income 0 0 3 0 1 0 0 2 1
Total Income 20 29 35 37 44 55 71 84 98
Total Expenditure -16 -23 -30 -31 -35 -42 -56 -66 -75
PBIDT 4 6 5 6 9 13 15 18 23
Interest -1 -4 -2 -2 -2 -1 -1 -1 -1
Depreciation -1 -1 -4 -4 -3 -3 -4 -4 -5
Taxation 0 0 1 -1 -3 -3 -4 -5
Exceptional Items 0
PAT 1 1 0 0 3 5 7 9 12

Cash Flow View Details

Particulars 9 years 2012-03 Rs. Cr. 2013-03 Rs. Cr. 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr.
Cash Fr. Operatn. 4 7 4 5 6 10 12 16 11
Cash Fr. Inv. -8 -7 -2 -1 -1 -4 -19 -9 -8
Cash Fr. Finan. 4 -3 -1 -5 -5 -5 6 -5 -4
Net Change 0 -3 0 0 0 1 -1 1 -1
Cash & Cash Eqvt 3 0 0 0 0 1 0 2 1

Shareholding Pattern View Details

9 Qtrs 2019-06 (%) 2019-09 (%) 2019-12 (%) 2020-03 (%) 2020-06 (%) 2020-09 (%) 2020-12 (%) 2021-03 (%) 2021-06 (%)
Promoter 75.00 75.00 75.00 75.00 75.00 75.00 75.00 75.00 75.00
Public 25.00 25.00 25.00 25.00 25.00 25.00 25.00 25.00 25.00
Depository Receipts 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Promoter Holding Pledge (%) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

Announcements View Details

Tue, 27 Jul 2021
Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Pursuant to Regulations 39(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 we bring to your kind notice the information received from shareholders through our RTA regarding the loss of share certificates and requesting for issue of duplicate share certificates as per the details attached

Tue, 20 Jul 2021
Statement Of Investor Complaints For The Quarter Ended June 2021 (Revised)
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter
0110
Name of the Signatory :- Yasotha Benazir N
Designation :- Company Secretary and Compliance Officer
Tue, 20 Jul 2021
Statement Of Investor Complaints For The Quarter Ended June 2021 (Revised)
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter
0110
Name of the Signatory :- Yasotha Benazir N
Designation :- Company Secretary and Compliance Officer

Technical Scans View Details

Tue, 03 Aug 2021
High Delivery Percentage High Delivery Percentage
Closing Below Previous Low Closing Below Previous Low
CCI Crossed Below -100 CCI Crossed Below -100
MFI Trending Down MFI Trending Down
William %R Crossed -80 From Above William %R Crossed -80 From Above

Related Stocks View Details

Stock Name Market Cap(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. 190,711.14 794.85 +2.6%
Divi's Laboratories Ltd. 132,945.34 4,990.05 +1.3%
Dr. Reddy's Laboratories Ltd. 78,541.95 4,721.20 +0.4%
Cipla Ltd. 74,795.92 927.25 +0.6%
Cadila Healthcare Ltd. 60,600.44 592.10 +0.1%
Apollo Hospitals Enterprise Ltd. 58,835.96 4,076.05 +0.7%
Piramal Enterprises Ltd. 56,942.27 2,507.65 +0.7%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2021-06 31.77 794.85 +2.6%
Divi's Laboratories Ltd. Consolidated 2021-03 67.00 4,990.05 +1.3%
Dr. Reddy's Laboratories Ltd. Consolidated 2021-06 45.21 4,721.20 +0.4%
Cipla Ltd. Consolidated 2021-03 31.10 927.25 +0.6%
Cadila Healthcare Ltd. Consolidated 2021-03 28.40 592.10 +0.1%
Apollo Hospitals Enterprise Ltd. Consolidated 2021-03 391.30 4,076.05 +0.7%
Piramal Enterprises Ltd. Consolidated 2021-03 42.74 2,507.65 +0.7%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2021-06 3.98 794.85 +2.6%
Divi's Laboratories Ltd. Consolidated 2021-03 14.30 4,990.05 +1.3%
Dr. Reddy's Laboratories Ltd. Consolidated 2021-06 4.39 4,721.20 +0.4%
Cipla Ltd. Consolidated 2021-03 4.09 927.25 +0.6%
Cadila Healthcare Ltd. Consolidated 2021-03 4.66 592.10 +0.1%
Apollo Hospitals Enterprise Ltd. Consolidated 2021-03 12.80 4,076.05 +0.7%
Piramal Enterprises Ltd. Consolidated 2021-03 1.66 2,507.65 +0.7%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2020-03 0.18 794.85 +2.6%
Divi's Laboratories Ltd. Consolidated 2020-03 0.00 4,990.05 +1.3%
Dr. Reddy's Laboratories Ltd. Consolidated 2021-03 0.17 4,721.20 +0.4%
Cipla Ltd. Consolidated 2020-03 0.18 927.25 +0.6%
Cadila Healthcare Ltd. Consolidated 2021-03 0.35 592.10 +0.1%
Apollo Hospitals Enterprise Ltd. Consolidated 2020-03 1.08 4,076.05 +0.7%
Piramal Enterprises Ltd. Consolidated 2021-03 1.16 2,507.65 +0.7%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2020-03 9.66 794.85 +2.6%
Divi's Laboratories Ltd. Consolidated 2020-03 19.30 4,990.05 +1.3%
Dr. Reddy's Laboratories Ltd. Consolidated 2021-03 11.53 4,721.20 +0.4%
Cipla Ltd. Consolidated 2020-03 10.09 927.25 +0.6%
Cadila Healthcare Ltd. Consolidated 2021-03 18.30 592.10 +0.1%
Apollo Hospitals Enterprise Ltd. Consolidated 2020-03 13.08 4,076.05 +0.7%
Piramal Enterprises Ltd. Consolidated 2021-03 3.33 2,507.65 +0.7%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2020-03 10.07 794.85 +2.6%
Divi's Laboratories Ltd. Consolidated 2020-03 25.36 4,990.05 +1.3%
Dr. Reddy's Laboratories Ltd. Consolidated 2021-03 15.24 4,721.20 +0.4%
Cipla Ltd. Consolidated 2020-03 12.53 927.25 +0.6%
Cadila Healthcare Ltd. Consolidated 2021-03 13.65 592.10 +0.1%
Apollo Hospitals Enterprise Ltd. Consolidated 2020-03 17.13 4,076.05 +0.7%
Piramal Enterprises Ltd. Consolidated 2021-03 10.03 2,507.65 +0.7%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2020-03 32,837.50 794.85 +2.6%
Divi's Laboratories Ltd. Consolidated 2020-03 5,394.42 4,990.05 +1.3%
Dr. Reddy's Laboratories Ltd. Consolidated 2021-03 19,047.50 4,721.20 +0.4%
Cipla Ltd. Consolidated 2020-03 19,159.59 927.25 +0.6%
Cadila Healthcare Ltd. Consolidated 2021-03 15,102.20 592.10 +0.1%
Apollo Hospitals Enterprise Ltd. Consolidated 2020-03 11,246.80 4,076.05 +0.7%
Piramal Enterprises Ltd. Consolidated 2021-03 12,809.35 2,507.65 +0.7%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2020-03 4,186.79 794.85 +2.6%
Divi's Laboratories Ltd. Consolidated 2020-03 1,376.54 4,990.05 +1.3%
Dr. Reddy's Laboratories Ltd. Consolidated 2021-03 1,903.60 4,721.20 +0.4%
Cipla Ltd. Consolidated 2020-03 2,401.30 927.25 +0.6%
Cadila Healthcare Ltd. Consolidated 2021-03 2,137.60 592.10 +0.1%
Apollo Hospitals Enterprise Ltd. Consolidated 2020-03 434.90 4,076.05 +0.7%
Piramal Enterprises Ltd. Consolidated 2021-03 1,074.43 2,507.65 +0.7%